लोड हो रहा है...

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Although the clinical development of immune checkpoint inhibitors (ICIs) therapy has ushered in a new era of anti-tumor therapy, with sustained responses and significant survival advantages observed in multiple tumors, most patients do not benefit. Therefore, more and more attention has been paid to...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Biomark Res
मुख्य लेखकों: Bai, Rilan, Lv, Zheng, Xu, Dongsheng, Cui, Jiuwei
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7450548/
https://ncbi.nlm.nih.gov/pubmed/32864131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00209-0
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!